Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vancomycin Dosing Methods for MRSA
NCT03412500Phase 4Unknown
- Start
- Oct 2016
- Primary completion
- Sep 2018
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vancomycin in Staphylococcus aureus infection. Status: unknown.
02
Drugs
vancomycin
03
Conditions
Staphylococcus aureus infection
Beyond the preview
Go deeper on NCT03412500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03412500.